Triton Market Research’s report shows that the insulin patch pump market in North America will register a CAGR of 11.00% in the forecast years from 2023 to 2030. Canada and the United States are analyzed in the market in this region.
The rising prevalence of diabetes among Americans has driven the demand for insulin patch pumps. Moreover, the adoption of smart devices and technological advancements like data analytics & artificial intelligence are estimated to fuel the market’s growth in the country.
The presence of established market players, such as Tandem Diabetes Care, Medtronic, and Insulet Corporation, is also expected to favor the market’s development in the US during the forecast period.
Building on the legacy of the discovery of insulin by a team of Canadian researchers in 1921, Canada is home to a number of internationally recognized diabetes researchers. Its government has collaborated with several partners and invests in health research so as to develop systems for the prevention, diagnosis, and treatment for the condition.
For instance, the CIHR (the Canadian Institutes of Health Research) and JDRF Canada (Juvenile Diabetes Research Foundation) announced the CIHR-JDRF Partnership to Defeat Diabetes to jointly invest $30 million in the research of type 1 diabetes. In 2021, this partnership was renewed with an additional investment of $15 million from the Budget 2021. These developments are expected to favor the adoption of insulin patch pumps in the country over the coming years.
Competitive Outlook
The noteworthy players in the insulin patch pump market are Medtrum Technologies Inc, Medtronic Plc, EOFlow Co Ltd, Insulet Corporation, and Tandem Diabetes Care Inc.
1. North America Insulin Patch Pump Market – Summary
2. Industry Outlook
2.1. Parent Market Analysis
2.2. Impact Analysis On The Insulin Patch Pump Market
2.2.1. Covid-19 Impact
2.2.2. Ukraine-russia War Impact
2.3. Porter’s Five Forces Analysis
2.3.1. Threat Of New Entrants
2.3.2. Threat Of Substitutes
2.3.3. Bargaining Power Of Buyers
2.3.4. Bargaining Power Of Suppliers
2.3.5. Threat Of Competitive Rivalry
2.4. Market Maturity Analysis
2.5. Industry Components
2.5.1. Research And Development
2.5.2. Development Of Product
2.5.3. Distribution
2.6. Regulatory Framework
2.7. Key Buying Impact Analysis
2.7.1. Price
2.7.2. Properties Of Product
2.7.3. Purpose
2.8. Key Market Strategies
2.8.1. Collaborations
2.8.2. Product Launches
2.8.3. Mergers & Acquisitions
2.9. Market Drivers
2.9.1. Growing Awareness About Insulin Patch Pumps
2.9.2. Integration Of Advanced Technologies
2.9.3. Rising Prevalence Of Diabetes Around The Globe
2.10. Market Challenges
2.10.1. Risks Related To The Use Of Insulin Pumps
2.10.2. Lack Of Knowledge Pertaining To Usage
2.10.3. Strict Regulations By Government Authorities
2.11. Market Opportunities
2.11.1. Increasing Popularity Of Glucose Monitoring Systems
2.11.2. Use Of Artificial Intelligence & Machine Learning For Manufacturing Of Insulin Pumps
2.11.3. Growing Expenditure On Diabetes Care
2.11.4. Rising Demand For Minimally Invasive Delivery Systems
2.12. Analyst Perspective
3. North America Insulin Patch Pump Market – By Product Type
3.1. Disposable
3.2. Reusable
4. North America Insulin Patch Pump Market – By Disease Indication
4.1. Type 1 Diabetes
4.2. Type 2 Diabetes
5. North America Insulin Patch Pump Market – By Delivery Mode
5.1. Basal
5.2. Bolus
5.3. Basal & Bolus
6. North America Insulin Patch Pump Market – By Distribution Channel
6.1. Online Pharmacies
6.2. Retail Pharmacies
6.3. Hospital Pharmacies
7. North America Insulin Patch Pump Market – Country Outlook
7.1. Country Analysis
7.1.1. United States
7.1.1.1. United States Insulin Patch Pump Market Forecast & Prospects